Patent · US Active

RNase H-based assays utilizing modified RNA monomers

US10227641B2 · kind B2 · utility

1Cited by
12References
55Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 2, 2013
Grant dateMar 12, 2019
Priority date
Expiry dateNov 9, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y301/26004
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods and compositions are provided for improving specificity during amplification of a target DNA sequence. The methods and compositions rely upon the use of an RNase H enzyme, a polymerase, and RNase H enzyme-sensitive, blocked-cleavable oligonucleotide primers in the amplification reactions, wherein the reaction mixtures include either an optimized final concentration of a divalent metal salt comprising 2.0 mM or less of free Mg++ cation and/or an optimized final concentration of a non-ionic detergent comprising at least about 0.001% polyethylene glycol hexadecyl ether.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.